Skip to main content
Equibles
MD logo

MD · Pediatrix Medical Group, Inc.

Track MD — free

Use MD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$27.03 +0.15 (+0.56%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.20B
Shares
81.25M

MD metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$27.03
Market cap
$2.20B

Price action

19 metrics
Price change (1W)
+1.6%
Price change (30D)
+3.6%
Price change (3M)
+19.5%
Price change (6M)
+36.9%
Price change (YTD)
+26.4%
Price change (1Y)
+58.9%
Trailing year
Price change (5Y)
-12.7%
52-week high
$27.39
52-week low
$15.80
Change from 52-week high
-1.3%
Change from 52-week low
+71.1%
Annualized volatility
42.5%
Beta
0.5
RSI (14D)
57.4
Price vs SMA 50
+2.8%
Price vs SMA 200
+17.6%
Avg volume (3M)
790,194
Relative volume
0.7
Average dollar volume
$20.27M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
81.25M

Valuation

12 metrics
P / E (TTM)
12.9
Trailing earnings · reciprocal yield 7.7%
PEG ratio
2.0
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.1×
reciprocal yield 88.8%
P / book
2.5
reciprocal yield 40.1%
FCF yield
—
TTM · current market cap
Buyback yield
6.8%
P / FCF
—
P / operating cash flow
8.9
reciprocal yield 11.2%
Earnings yield
8.0%

Historical valuation

8 metrics
P / E historical average (3Y)
10.3×
reciprocal yield 9.7%
P / E historical average (5Y)
21.7×
reciprocal yield 4.6%
EV / revenue historical average (3Y)
0.9×
reciprocal yield 116.1%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 97.6%
EV / EBIT historical average (3Y)
32.8×
reciprocal yield 3.0%
EV / EBIT historical average (5Y)
22.0×
reciprocal yield 4.5%
EV / EBITDA historical average (3Y)
15.3×
reciprocal yield 6.5%
EV / EBITDA historical average (5Y)
13.2×
reciprocal yield 7.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
11.0%
Trailing 12 months
Net margin
9.0%
Gross profit (TTM)
—
Operating profit (TTM)
$215.42M
Net income (TTM)
$174.81M
Trailing 12 months
Diluted EPS (TTM)
$2.09
FCF margin
—
Effective tax rate
22.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$25.34

Growth

11 metrics
Revenue growth YoY
+4.0%
Year over year
Net income growth YoY
+1.5%
Revenue (TTM)
$1.95B
Trailing 12 months
EPS growth YoY
+6.5%
Shares change YoY
-4.8%
Year over year · fewer shares
Revenue CAGR (3Y)
-1.0%
Revenue CAGR (5Y)
+2.0%
EPS CAGR (3Y)
+34.9%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
19.8%
Return on assets
8.2%
Debt / equity
—
Current ratio
1.3
EBITDA (TTM)
$238.51M
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
6.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$288.88M
Total assets
$2.13B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$246.86M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$20.23M
R&D / revenue
—
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
304
13F filer change QoQ
+7
Institutional ownership
102.9%

Short interest

3 metrics
Short interest
6.1%
Latest settlement · 5.4 days to cover
Days to cover
5.4d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 893949 CUSIP 58502B106 13F (30d) 188 filings 187 filers Visit website Investor relations